Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

Related Articles by Review for PubMed (Select 17704212)

1.

Loss of the alpha7 integrin promotes extracellular signal-regulated kinase activation and altered vascular remodeling.

Welser JV, Lange N, Singer CA, Elorza M, Scowen P, Keef KD, Gerthoffer WT, Burkin DJ.

Circ Res. 2007 Sep 28;101(7):672-81. Epub 2007 Aug 17.

2.

Transplant atherosclerosis: role of phenotypic modulation of vascular smooth muscle by nitric oxide.

Bundy RE, Marczin N, Birks EF, Chester AH, Yacoub MH.

Gen Pharmacol. 2000 Feb;34(2):73-84. Review.

PMID:
10974414
3.

Mechanisms of vascular smooth muscle cell migration.

Gerthoffer WT.

Circ Res. 2007 Mar 16;100(5):607-21. Review.

4.

Role of big mitogen-activated protein kinase 1 (BMK1) / extracellular signal-regulated kinase 5 (ERK5) in the pathogenesis and progression of atherosclerosis.

Yoshizumi M, Kyotani Y, Zhao J, Nagayama K, Ito S, Tsuji Y, Ozawa K.

J Pharmacol Sci. 2012;120(4):259-63. Epub 2012 Nov 20. Review.

5.

Signal transduction of mechanical stresses in the vascular wall.

Lehoux S, Tedgui A.

Hypertension. 1998 Aug;32(2):338-45. Review.

6.

G beta gamma-mediated signaling: new therapeutic target for proliferative vascular disease.

Iaccarino G, Koch WJ.

IUBMB Life. 1999 Sep;48(3):257-61. Review.

PMID:
10690635
7.

Age-related changes in the signaling and function of vascular smooth muscle cells.

Lundberg MS, Crow MT.

Exp Gerontol. 1999 Jul;34(4):549-57. Review.

PMID:
10817810
8.

Control of smooth muscle cell proliferation--the role of the basement membrane.

Hedin U, Roy J, Tran PK, Lundmark K, Rahman A.

Thromb Haemost. 1999 Sep;82 Suppl 1:23-6. Review.

PMID:
10695481
9.

The alpha7beta1 integrin in muscle development and disease.

Burkin DJ, Kaufman SJ.

Cell Tissue Res. 1999 Apr;296(1):183-90. Review.

PMID:
10199978
10.

EVE and beyond, retro and prospective insights.

Rabinovitch M.

Am J Physiol. 1999 Jul;277(1 Pt 1):L5-12. Review.

11.
12.

Vascular smooth muscle cell migration: current research and clinical implications.

Willis AI, Pierre-Paul D, Sumpio BE, Gahtan V.

Vasc Endovascular Surg. 2004 Jan-Feb;38(1):11-23. Review.

PMID:
14760473
13.

Integrins and mechanotransduction of the vascular myogenic response.

Davis MJ, Wu X, Nurkiewicz TR, Kawasaki J, Davis GE, Hill MA, Meininger GA.

Am J Physiol Heart Circ Physiol. 2001 Apr;280(4):H1427-33. Review.

14.

The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.

Chen G, Manji HK.

Curr Opin Psychiatry. 2006 May;19(3):313-23. Review.

PMID:
16612219
15.

Integrins and regulation of the microcirculation: from arterioles to molecular studies using atomic force microscopy.

Martinez-Lemus LA, Sun Z, Trache A, Trzciakowski JP, Meininger GA.

Microcirculation. 2005 Jan-Feb;12(1):99-112. Review.

PMID:
15804978
16.

Chemokines in vascular remodeling.

Schober A, Zernecke A.

Thromb Haemost. 2007 May;97(5):730-7. Review.

PMID:
17479183
17.

New insights into elastin and vascular disease.

Brooke BS, Bayes-Genis A, Li DY.

Trends Cardiovasc Med. 2003 Jul;13(5):176-81. Review.

PMID:
12837579
18.

Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury?

Albinsson S, Sessa WC.

Physiol Genomics. 2011 May 1;43(10):529-33. doi: 10.1152/physiolgenomics.00146.2010. Epub 2010 Sep 14. Review.

19.

[The effect of lipoproteins on signal transduction in thrombocytes and vascular wall cells].

Bochkov VN, Tkachuk VA.

Ross Fiziol Zh Im I M Sechenova. 2005 Jan;91(1):12-30. Review. Russian.

PMID:
15773577
20.

Integrins: novel therapeutic targets for cardiovascular diseases.

Lal H, Guleria RS, Foster DM, Lu G, Watson LE, Sanghi S, Smith M, Dostal DE.

Cardiovasc Hematol Agents Med Chem. 2007 Apr;5(2):109-32. Review.

PMID:
17430135
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk